Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'FORMOTEROL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 238 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Johnson, M; Hagan, GWE
      Long-acting beta(2)-agonists

      NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    2. Nelson, HS
      Combination therapy of bronchial asthma

      ALLERGY AND ASTHMA PROCEEDINGS
    3. Kips, JC
      Treating asthma, or is simple too simple?

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    4. O'Byrne, PM; Barnes, PJ; Rodriguez-Roisin, R; Runnerstrom, E; Sandstrom, T; Svensson, K; Tattersfield, A
      Low dose inhaled budesonide and formoterol in mild persistent asthma - TheOPTIMA randomized trial

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    5. Wilson, SJ; Wallin, A; Della-Cioppa, G; Sandstrom, T; Holgate, ST
      Effects of budesonide and formoterol on NF-kappa B, adhesion molecules, and cytokines in asthma

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    6. Dahl, R; Greefhorst, LAPM; Nowak, D; Nonikov, V; Byrne, AM; Thomson, MH; Till, D; Della Cioppa, G
      Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    7. Berggren, F; Ekstrom, T
      A cost-effectiveness study comparing the as-needed use of formoterol (Oxis(R)) and terbutaline (Bricanyl (R)) in patients with moderate to severe asthma

      RESPIRATORY MEDICINE
    8. Carlsen, KH; Hem, E; Stensrud, T; Held, T; Herland, K; Mowinckel, P
      Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta(2)-agonist formoterol upon endurance performance inhealthy well-trained athletes

      RESPIRATORY MEDICINE
    9. Vilsvik, J; Ankerst, J; Palmqvist, M; Persson, G; Schaanning, J; Schwabe, G; Johansson, A
      Protection against cold air and exercise-induced bronchoconstriction whileon regular treatment with Oxis((R))

      RESPIRATORY MEDICINE
    10. Andersson, F; Stahl, E; Barnes, PJ; Lofdahl, CG; O'Byrne, PM; Pauwels, RA; Postma, DS; Tattersfield, AE; Ullman, A
      Adding formoterol to budesonide in moderate asthma - health economic results from the FACET study

      RESPIRATORY MEDICINE
    11. Cazzola, M; Di Perna, F; D'Amato, M; Califano, C; Matera, MG; D'Amato, G
      Formoterol Turbuhaler (R) for as-needed therapy in patients with mild acute exacerbations of COPD

      RESPIRATORY MEDICINE
    12. Benhamou, D; Cuvelier, A; Muir, JF; Leclerc, V; Le Gros, V; Kottakis, J; Bourdeix, I
      Rapid onset of bronchodilation in COPD: a placebo-controlled study comparing formoterol (Foradil (R) Aerolizer (TM)) with salbutamol (Ventodisk (TM))

      RESPIRATORY MEDICINE
    13. Molimard, M; Bourcereau, J; Le Gros, V; Bourdeix, I; Leynadier, F; Duroux, P
      Comparison between formoterol 12 mu g b.i.d. and on-demand salbutamol in moderate persistent asthma

      RESPIRATORY MEDICINE
    14. Sears, MR
      The evolution of beta(2)-agonists

      RESPIRATORY MEDICINE
    15. Lotvall, J
      Pharmacological similarities and differences between beta(2)-agonists

      RESPIRATORY MEDICINE
    16. Barnes, PJ
      Clinical outcome of adding long-acting beta-agonists to inhaled corticosteroids

      RESPIRATORY MEDICINE
    17. Selroos, O
      Formoterol used as needed - clinical effectiveness

      RESPIRATORY MEDICINE
    18. Rabe, KF
      Formoterol in clinical practice - safety issues

      RESPIRATORY MEDICINE
    19. Pauwels, R
      Formoterol - where does it fit in the current guidelines?

      RESPIRATORY MEDICINE
    20. Zetterstrom, O; Buhl, R; Mellem, H; Perpina, M; Hedman, J; O'Neill, S; Ekstrom, T
      Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone

      EUROPEAN RESPIRATORY JOURNAL
    21. van der Woude, HJ; Aalbers, R
      Unaltered perception of dyspnoea during treatment with long-acting beta(2)-agonists

      EUROPEAN RESPIRATORY JOURNAL
    22. Knox, AJ; Zhu, YM; Pang, L
      Do long-acting beta(2)-adrenoceptor agonists enhance the anti-inflammatoryeffect of glucocorticoids in asthma?

      EUROPEAN RESPIRATORY JOURNAL
    23. Korn, SH; Jerre, A; Brattsand, R
      Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells

      EUROPEAN RESPIRATORY JOURNAL
    24. Jones, SL; Cowan, JO; Flannery, EM; Hancox, RJ; Herbison, GP; Taylor, DR
      Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol

      EUROPEAN RESPIRATORY JOURNAL
    25. Kirsch, L; Zhang, S; Muangsiri, W; Redmon, M; Luner, P; Wurster, D
      Development of a lyophilized formulation for (R,R)-formoterol (L)-tartrate

      DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
    26. Devillier, P
      beta 2 agonist and corticosteroid additive or synergy.

      REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
    27. Senn, S
      Statistical issues in bioequivalance

      STATISTICS IN MEDICINE
    28. Eccles, M; Rousseau, N; Higgins, B; Thomas, L
      Evidence-based guideline on the primary care management of asthma

      FAMILY PRACTICE
    29. Condemi, JJ
      Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: A multicenter, randomized, open-labeltrial

      CLINICAL THERAPEUTICS
    30. Lipworth, BJ; Currie, G; Fowler, S
      On-demand relief treatment for asthma

      LANCET
    31. Tattersfield, AE; Lofdahl, CG; Postma, DS; Eivindson, A; Schreurs, AGM; Rasidakis, A; Ekstrom, T
      Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial

      LANCET
    32. Matz, J; Emmett, A; Rickard, K; Kalberg, C
      Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    33. van der Woude, HJ; Winter, TH; Aalbers, R
      Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta(2) agonists

      THORAX
    34. Tattersfield, AE; Town, GI; Johnell, O; Picado, C; Aubier, M; Braillon, P; Karlstrom, R
      Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years

      THORAX
    35. Stephan, V; Griese, M; Reinhardt, D
      New aspects in the medical treatment of asthma

      MONATSSCHRIFT KINDERHEILKUNDE
    36. Cazzola, M; Centanni, S; Boveri, B; Di Marco, F; Santus, P; Matera, MG; Allegra, L
      Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease

      RESPIRATION
    37. Kallstrom, BL; Waldeck, B
      Bronchodilating properties of the VIP receptor agonist Ro 25-1553 comparedto those of formoterol on the guinea-pig isolated trachea

      EUROPEAN JOURNAL OF PHARMACOLOGY
    38. McGavin, JK; Goa, KL; Jarvis, B
      Inhaled budesonide/formoterol combination

      DRUGS
    39. Johnson, M; Rennard, S
      Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD

      CHEST
    40. Lipworth, BJ
      Lost in the labyrinth of end points

      CHEST
    41. Cloosterman, SGM; Bijl-Hofland, ID; van Herwaarden, CLA; Akkermans, RP; van den Elshout, FJJ; Folgering, HTM; van Schayck, CP
      A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients

      CHEST
    42. D'Urzo, AD; De Salvo, MC; Ramirez-Rivera, A; Almeida, J; Sichletidis, L; Rapatz, G; Kottakis, J
      In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium - A 3-week, randomized, double-blind, within-patient, multicenter study

      CHEST
    43. Wilson, AM; Dempsey, OJ; Sims, EJ; Lipworth, BJ
      Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids

      CHEST
    44. Lipworth, BJ
      Salmeterol and conventional asthma therapy

      CHEST
    45. Gu, JM; He, QJ; Gao, Q; Wang, HL; Huo, L; Wang, Q; Wang, ZS; Li, SQ; Tan, MQ; Zhang, FC; You, JH; Yamamoto, M
      Open-label, uncontrolled clinical study of formoterol, a selective beta(2)-receptor agonist, in patients with bronchial asthma and asthmatic bronchitis

      CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL
    46. Verberne, AAPH; de Jongste, JC
      Long-acting beta(2)-agonists in childhood asthma: Don't change a winning team (yet)

      PEDIATRIC PULMONOLOGY
    47. Bisgaard, H
      Long-acting beta(2)-agonists in management of childhood asthma: A criticalreview of the literature

      PEDIATRIC PULMONOLOGY
    48. Wilkinson, HS; Hett, R; Tanoury, GJ; Senanayake, CH; Wald, SA
      Modulation of catalyst reactivity for the chemoselective hydrogenation of a functionalized nitroarene: Preparation of a key intermediate in the synthesis of (R,R)-formoterol tartrate

      ORGANIC PROCESS RESEARCH & DEVELOPMENT
    49. Visser, TJ; van der Wouden, EA; van Waarde, A; Doze, P; Elsinga, PH; Vaalburg, W
      Synthesis and biodistribution of [C-11]procaterol, a beta(2)-adrenoceptor agonist for positron emission tomography

      APPLIED RADIATION AND ISOTOPES
    50. Gronnerod, TA; von Berg, A; Schwabe, G; Soliman, S
      Formoterol via Turbuhaler (R) gave better protection than terbutaline against repeated exercise challenge for up to 12 hours in children and adolescents

      RESPIRATORY MEDICINE
    51. Lundback, B; Jenkins, C; Price, MJ; Thwaites, RMA
      Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 mu g twice daily and budesonide 800 mu g twice daily in the treatment of adults and adolescents with asthma

      RESPIRATORY MEDICINE
    52. Seberova, E; Andersson, A
      Oxis (R) (formoterol given by Turbuhaler (R)) showed as rapid an onset of action as salbutamol given by a pMDI

      RESPIRATORY MEDICINE
    53. Howarth, PH; Beckett, P; Dahl, R
      The effect of long-acting beta(2)-agonists on airway inflammation in asthmatic patients

      RESPIRATORY MEDICINE
    54. van Noord, JA; de Munck, DRAJ; Bantje, TA; Hop, WCJ; Akveld, MLM; Bommer, AL
      Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium

      EUROPEAN RESPIRATORY JOURNAL
    55. van Schayck, CP
      Do long-acting beta(2)-adrenergic agonists deserve a different place in guidelines for the treatment of asthma and COPD?

      EUROPEAN RESPIRATORY JOURNAL
    56. Spoelstra, FM; Postma, DS; Hovenga, H; Noordhoek, JA; Kauffman, HF
      Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts

      EUROPEAN RESPIRATORY JOURNAL
    57. Molimard, M; Marthan, R
      Genetic polymorphism and asthma

      REVUE DES MALADIES RESPIRATOIRES
    58. Derks, MGM; Koopmans, RP; Oosterhoff, E; Van Boxtel, CJ
      Prevention by theophylline of beta-2-receptor down regulation in healthy subjects

      EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    59. He, P; Wang, J; Zeng, M
      Leukocyte adhesion and microvessel permeability

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    60. Magnan, A; Romanet, S; Boniface, S; Vervloet, D
      Long-lasting beta(2)-agonists in asthma: current prospects

      REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
    61. Zhang, M; Fawcett, JP; Kennedy, JM; Shaw, JP
      Stereoselective glucuronidation of formoterol by human liver microsomes

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    62. Kavuru, M; Melamed, J; Gross, G; LaForce, C; House, K; Prillaman, B; Baitinger, L; Woodring, A; Shah, T
      Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    63. Guhan, AR; Cooper, S; Oborne, J; Lewis, S; Bennett, J; Tattersfield, AE
      Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects

      THORAX
    64. Rosenborg, J; Bengtsson, T; Larsson, P; Blomgren, A; Persson, G; Lotvall, J
      Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    65. Schmidt, D; Kallstrom, BL; Waldeck, B; Branscheid, D; Magnussen, H; Rabe, KF
      The effect of the enantiomers of formoterol on inherent and induced tone in guinea-pig trachea and human bronchus

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    66. Ferrari, M; Balestreri, F; Baratieri, S; Biasin, C; Oldani, V; Lo Cascio, V
      Evidence of the rapid protective effect of formoterol dry-powder inhalation against exercise-induced bronchospasm in athletes with asthma

      RESPIRATION
    67. Centanni, S; Carlucci, P; Santus, P; Boveri, B; Tarricone, D; Fiorentini, C; Lombardi, F; Cazzola, M
      Non-pulmonary effects induced by the addition of formoterol to budesonide therapy in patients with mild or moderate persistent asthma

      RESPIRATION
    68. Cazzola, M; Donner, CF
      Long-acting beta(2) agonists in the management of stable chronic obstructive pulmonary disease

      DRUGS
    69. Aziz, I; Wilson, AM; Lipworth, BJ
      Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults

      CHEST
    70. Lipworth, BJ; Dempsey, OJ; Aziz, I
      Functional antagonism with formoterol and salmeterol in asthmatic patientsexpressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism

      CHEST
    71. Dempsey, OJ; Wilson, AM; Sims, EJ; Mistry, C; Lipworth, BJ
      Additive bronchoprotective and bronchodilator effects with single doses ofsalmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids

      CHEST
    72. Lipworth, BJ; Aziz, I
      Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration

      CHEST
    73. Marzo, A; Monti, NC; Tettamanti, RA; Crivelli, F; Dal Bo, L; Mazzucchelli, P; Meoli, A; Pezzuto, D; Corsico, A
      Bioequivalence of inhaled formoterol fumarate assessed from pharmacodynamic, safety and urinary pharmacokinetic data

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    74. Heuck, C; Heickendorff, L; Wolthers, OD
      A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide

      ARCHIVES OF DISEASE IN CHILDHOOD
    75. Lipworth, BJ; Dempsey, OJ; Aziz, I; Wilson, AM
      Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype

      AMERICAN JOURNAL OF MEDICINE
    76. Lundback, B; Pieters, WR; Johansson, G; Palmqvist, M; Price, MJ; Sondhi, S; Thwaites, RMA
      Cost-effectiveness analyses of salmeterol/fluticasone propionate combination product and fluticasone propionate in patients with asthma I: Introduction and overview

      PHARMACOECONOMICS
    77. Pieters, WR; Lundback, B; Sondhi, S; Price, MJ; Thwaites, RMA
      Cost-effectiveness analysis of salmeterol/fluticasone propionate 50/500 mug vs fluticasone propionate 500 mu g in patients with corticosteroid-dependent asthma V: Results

      PHARMACOECONOMICS
    78. Martin, RJ; Kraft, M; Beaucher, WN; Kiechel, F; Sublett, JL; LaVallee, N; Shilstone, J
      Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma

      ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    79. Li, X; Ward, C; Thien, F; Bish, R; Bamford, T; Bao, XH; Bailey, M; Wilson, JW; Walters, EH
      An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    80. Tattersfield, AE; Postma, DS; Barnes, PJ; Svensson, K; Bauer, CA; O'Byrne, PM; Lofdahl, CG; Pauwels, RA; Ullman, A
      Exacerbations of asthma - A descriptive study of 425 severe exacerbations

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    81. Zhang, XY; Robinson, NE; Zhu, FX
      Modulation of ACh release from airway cholinergic nerves in horses with recurrent airway obstruction

      AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
    82. Cazzola, M; Matera, MG
      Should long-acting beta(2)-agonists be considered an alternative first choice option for the treatment of stable COPD?

      RESPIRATORY MEDICINE
    83. Nielsen, LP; Pedersen, B; Faurschou, P; Madsen, F; Wilcke, JTR; Dahl, R
      Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics

      RESPIRATORY MEDICINE
    84. Castellsague, J; Garcia-Rodriguez, LA; Perez-Gutthann, S; Agostinis, L; Cattaruzi, C; Troncon, MG
      Characteristics of users of inhaled long-acting beta(2)-agonists in a Southern European population

      RESPIRATORY MEDICINE
    85. Gerrits, CMJM; Herings, RMC; Leufkens, HGM; Lammers, JWJ
      Asthma exacerbations during first therapy with long acting beta 2-agonists

      PHARMACY WORLD & SCIENCE
    86. Juniper, EF; Svensson, K; O'Byrne, PM; Barnes, PJ; Bauer, CA; Lofdahl, CGA; Postma, DS; Pauwels, RA; Tattersfield, AE; Ullman, A
      Asthma quality of life during 1 year of treatment with budesonide with or without formoterol

      EUROPEAN RESPIRATORY JOURNAL
    87. Bouros, D; Bachlitzanakis, N; Kottakis, J; Pfister, P; Polychronopoulos, V; Papadakis, E; Constantopoulos, S; Froudarakis, M; Sichletidis, L; Siafakas, N
      Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma

      EUROPEAN RESPIRATORY JOURNAL
    88. Politiek, MJ; Boorsma, M; Aalbers, R
      Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction

      EUROPEAN RESPIRATORY JOURNAL
    89. Maesen, BLP; Westermann, CJJ; Duurkens, VAM; van den Bosch, JMM
      Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease

      EUROPEAN RESPIRATORY JOURNAL

    90. beta(2)-agonists - Short-acting beta(2)-agonists

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    91. Song, JZ; Chen, J; Tian, SJ; Sun, ZP
      Assay for the determination of low dosage form of formoterol dry syrup by capillary electrophoresis with head-column field-amplified sample stacking

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    92. de Blic, J
      Exercise-induced asthma in children: place of beta 2-LA and leukotriene inhibitors

      REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
    93. Ochsner, M; Jaekel, K; Mutz, M; Anderson, GP; John, E
      Comparative biophysical analysis of the interaction of bronchodilating beta(2)-adrenoceptor agonists with lipid membranes

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    94. Lipworth, BJ; Hall, IP; Aziz, I; Tan, KS; Wheatley, A
      beta(2)-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta(2)-agonist therapy

      CLINICAL SCIENCE
    95. Verberne, AAPH
      Options for bronchodilation in children: can we rely on adult data?

      ALLERGY
    96. Aziz, I; Lipworth, BJ
      In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    97. Lipworth, BJ; Aziz, I
      A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    98. van Noord, JA; Schreurs, AJM; Mol, SJM; Mulder, PGH
      Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma

      THORAX
    99. Cazzola, M; Calderaro, F; Califano, C; Di Pema, F; Vinciguerra, A; Donner, CF; Matera, MG
      Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    100. Milgrom, H; Taussig, LM
      Keeping children with exercise-induced asthma active

      PEDIATRICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/08/20 alle ore 16:10:54